---
schema_version: "secwatch.filing_event.v1"
accession: "0001453687-23-000064"
form_type: "8-K"
ticker: "RNAC"
cik: "0001453687"
company_name: "Cartesian Therapeutics, Inc."
filed_at: "2023-09-25T23:59:59+00:00"
generated_at: "2026-06-10T09:11:50.747489+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Selecta Biosciences approves retention bonuses for five executives

## Summary
- Carsten Brunn (CEO) and Blaine Davis each receive 2x annual salary bonus; Peter Traber 1.5x; Takashi Kei Kishimoto 1x; Lloyd Johnston 2x.
- Bonus payable on first payroll after March 31, 2024 if executive remains employed in good standing.
- Compensation Committee may accelerate payment or waive service requirements at its discretion.
- Retention bonuses aim to incentivize key leadership continuity through March 2024.

## SEC filing metadata
- accession: 0001453687-23-000064
- form_type: 8-K
- ticker: RNAC
- cik: 0001453687
- company_name: Cartesian Therapeutics, Inc.
- filed_at: 2023-09-25T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1453687/000145368723000064/0001453687-23-000064-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1453687/000145368723000064/selb-20230825.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001453687-23-000064
- JSON: https://secwatch.observer/filing/0001453687-23-000064.json
- Plain text: https://secwatch.observer/filing/0001453687-23-000064.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.